United States
Securities and Exchange Commission
Washington, D.C. 20549
Schedule 13G
(Rule 13d-102)
Information to be Included in Statements Filed Pursuant
to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed
Pursuant to § 240.13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. )*
Atea Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value $0.001
(Title of Class of Securities)
04683R106
(CUSIP Number)
December 31, 2020
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 04683R106 | Schedule 13G | Page 1 of 6 |
| 1 | Names of Reporting Persons
JPM Partners LLC | |||||
| 2 | Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☐
| |||||
| 3 | SEC Use Only
| |||||
| 4 | Citizenship or Place of Organization
Delaware | |||||
| Number of Shares Beneficially Owned by Each Reporting Person With |
5 | Sole Voting Power
0 | ||||
| 6 | Shared Voting Power
5,925,000 | |||||
| 7 | Sole Dispositive Power
0 | |||||
| 8 | Shared Dispositive Power
5,925,000 | |||||
| 9 |
Aggregate Amount Beneficially Owned by Each Reporting Person
5,925,000 | |||||
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares
Not Applicable | |||||
| 11 | Percent of Class Represented by Amount in Row 9
7.2% | |||||
| 12 | Type of Reporting Person
OO (Limited Liability Company) | |||||
| CUSIP No. 04683R106 | Schedule 13G | Page 2 of 6 |
| 1 | Names of Reporting Persons
Jean-Pierre Sommadossi | |||||
| 2 | Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☐
| |||||
| 3 | SEC Use Only
| |||||
| 4 | Citizenship or Place of Organization
United States | |||||
| Number of Shares Beneficially Owned by Each Reporting Person With |
5 | Sole Voting Power
876,664 | ||||
| 6 | Shared Voting Power
5,925,000 | |||||
| 7 | Sole Dispositive Power
876,664 | |||||
| 8 | Shared Dispositive Power
5,925,000 | |||||
| 9 |
Aggregate Amount Beneficially Owned by Each Reporting Person
6,801,664 | |||||
| 10 | Check if the Aggregate Amount in Row (9) Excludes Certain Shares
Not Applicable | |||||
| 11 | Percent of Class Represented by Amount in Row 9
8.2% | |||||
| 12 | Type of Reporting Person
IN | |||||
| CUSIP No. 04683R106 | Schedule 13G | Page 3 of 6 |
| ITEM 1. | (a) | Name of Issuer: | ||
| Atea Pharmaceuticals, Inc. (the “Issuer”). | ||||
| (b) | Address of Issuer’s Principal Executive Offices: | |||
| 125 Summer Street, Boston, MA 02110. | ||||
| ITEM 2. | (a) | Name of Person Filing: | ||
| Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of: | ||||
| JPM Partners LLC; and | ||||
| Jean-Pierre Sommadossi | ||||
| (b) | Address or Principal Business Office: | |||
| The business address of JPM Partners LLC is 2 Avery Street #21E, Boston, MA 02111. | ||||
| The business address of Jean-Pierre Sommadossi is 125 Summer Street, Boston, MA 02110. | ||||
| (c) | Citizenship: | |||
| JPM Partners LLC is a Delaware limited liability company. Dr. Sommadossi is a citizen of the United States. | ||||
| (d) | Title of Class of Securities: | |||
| Common stock, par value $0.001 per share (“Common Stock”). | ||||
| (e) | CUSIP Number: | |||
| 04683R106 | ||||
| ITEM 3. |
|
Not applicable.
| ITEM 4. | Ownership. |
The ownership information below represents beneficial ownership of shares of Common Stock as of December 31, 2020, based upon 82,616,937 shares of Common Stock outstanding as of December 10, 2020.
| CUSIP No. 04683R106 | Schedule 13G | Page 4 of 6 |
(a-c)
| Reporting Person | Amount beneficially owned |
Percent of class: |
Sole or to |
Shared power to vote or to direct the vote: |
Sole of: |
Shared power to dispose or to direct the disposition of: |
||||||||||||||||||
| JPM Partners LLC |
5,925,000 | 7.2 | % | 0 | 5,925,000 | 0 | 5,925,000 | |||||||||||||||||
| Jean-Pierre Sommadossi |
6,801,664 | 8.2 | % | 876,664 | 5,925,000 | 876,664 | 5,925,000 | |||||||||||||||||
JPM Partners LLC is the record holder of 5,925,000 shares of Common Stock. Dr. Sommadossi is the manager of JPM Partners LLC and may be deemed to share beneficial ownership of the securities held by JPM Partner LLC. In addition, Dr. Sommadossi beneficially owns 876,664 shares of Common Stock subject to stock options that are currently exercisable or will become exercisable within 60 days of December 31, 2020.
| ITEM 5. | Ownership of Five Percent or Less of a Class. |
Not applicable.
| ITEM 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable.
| ITEM 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. |
Not applicable.
| ITEM 8. | Identification and Classification of Members of the Group. |
Not applicable.
| ITEM 9. | Notice of Dissolution of Group. |
Not applicable.
| ITEM 10. | Certification. |
Not applicable.
| CUSIP No. 04683R106 | Schedule 13G | Page 5 of 6 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 10, 2021
| JPM Partners LLC | ||
| By: | /s/ Jean-Pierre Sommadossi | |
| Name: | Jean-Pierre Sommadossi | |
| Title: | Manager | |
| Jean-Pierre Sommadossi | ||
| /s/ Jean-Pierre Sommadossi | ||
| CUSIP No. 04683R106 | Schedule 13G | Page 6 of 6 |
LIST OF EXHIBITS
| Exhibit |
Description | |
| 99 | Joint Filing Agreement. | |
Exhibit 99
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13G. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of the 10th day of February, 2021.
| JPM Partners LLC | ||
| By: | /s/ Jean-Pierre Sommadossi | |
| Name: | Jean-Pierre Sommadossi | |
| Title: | Manager | |
| Jean-Pierre Sommadossi | ||
| /s/ Jean-Pierre Sommadossi | ||